Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SYK

SYK - Stryker Corp Stock Price, Fair Value and News

$357.89+3.32 (+0.94%)
Market Closed

49/100

SYK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

49/100

SYK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$317.41

Target 3M

$345.1

Target 6M

$335.51

SYK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SYK Price Action

Last 7 days

-1.4%

Last 30 days

1.5%

Last 90 days

-3.0%

Trailing 12 Months

-9.4%

SYK RSI Chart

SYK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SYK Valuation

Market Cap

136.7B

Price/Earnings (Trailing)

46.47

Price/Sales (Trailing)

5.61

EV/EBITDA

39.25

Price/Free Cashflow

33.57

SYK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$317.41

Target 3M

$345.1

Target 6M

$335.51

SYK Fundamentals

SYK Revenue

Revenue (TTM)

24.4B

Rev. Growth (Yr)

10.25%

Rev. Growth (Qtr)

0.58%

SYK Earnings

Earnings (TTM)

2.9B

Earnings Growth (Yr)

3%

Earnings Growth (Qtr)

-2.83%

SYK Profitability

Operating Margin

64.03%

EBT Margin

13.69%

Return on Equity

13.51%

Return on Assets

6.25%

Free Cashflow Yield

2.98%

SYK Investor Care

Dividend Yield

0.93%

Dividend/Share (TTM)

3.32

Shares Dilution (1Y)

0.26%

Diluted EPS (TTM)

7.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202523.2B23.8B24.4B0
202421.0B21.4B22.0B22.6B
202319.0B19.5B19.9B20.5B
202217.4B17.6B17.9B18.4B
202114.7B16.2B16.7B17.1B
202015.0B14.1B14.2B14.4B
201913.9B14.2B14.5B14.9B
201812.7B13.0B13.3B13.6B
201711.8B12.0B12.1B12.4B
201610.1B10.5B10.9B11.3B
20159.7B9.8B9.8B9.9B
20149.1B9.3B9.5B9.7B
20138.7B8.8B8.9B9.0B
20128.5B8.5B8.5B8.7B
20117.5B7.8B8.1B8.3B
20100007.3B
Get all data in R, Python etc through our Historical Stock Data APIs

About Stryker Corp

SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
 CEO
 WEBSITEstryker.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES51000

Stryker Corp Frequently Asked Questions

SYK is the stock ticker symbol of Stryker Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Stryker Corp is 136.75 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check SYK's fair value in chart for subscribers.

The fair value guage provides a quick view whether SYK is over valued or under valued. Whether Stryker Corp is cheap or expensive depends on the assumptions which impact Stryker Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SYK.

As of Wed Jan 28 2026, SYK's PE ratio (Price to Earnings) is 46.47 and Price to Sales (PS) ratio is 5.61. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SYK PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Stryker Corp has provided 0.137 (multiply by 100 for percentage) rate of return.